-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Mereo BioPharma Group plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2022 to Q3 2025.
- Mereo BioPharma Group plc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$7.02M, a 53.2% increase year-over-year.
- Mereo BioPharma Group plc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$41.6M, a 8.26% increase year-over-year.
- Mereo BioPharma Group plc annual Net Income (Loss) Attributable to Parent for 2024 was -$43.3M, a 46.8% decline from 2023.
- Mereo BioPharma Group plc annual Net Income (Loss) Attributable to Parent for 2023 was -$29.5M, a 30.2% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)